Carnegie Pharmaceuticals specializes in the development of unique generic and branded products possessing development barriers. The founder, Dr. Rakesh Grover, have the experience of developing a number of challenging products including patent challenges and setting up vertically integrated pharmaceutical companies that manufacture active raw materials, finished dosage forms and sell the finished products in the United States as well as globally. At Carnegie, a team of highly skilled and experienced scientists are developing challenging products using in-house technology platforms, technical know-how and prior experience. Carnegie is constantly seeking partnerships with individuals and companies to develop a portfolio of challenging and exciting projects.